pharmaphorum August 15, 2024
AstraZeneca’s plan to invest £450 million ($578 million) in a vaccines manufacturing plant in the UK has been thrown into doubt, claims a report in the Financial Times.
The Treasury, under new Chancellor of the Exchequer Rachel Reeves, is said to be seeking a reduction to the state aid package made available to support the project, which was held up as a vote of confidence in the UK’s life sciences sector when it was first reported earlier this year.
At the time, there were reports that the previous government was offering up to £100 million in subsidies for the investment programme at AZ’s site at Speke in Liverpool, earmarked for the construction of a new plant that would be powered...
Today's Sponsors
Today's Sponsor